1. A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months. Issue 6 (30th November 2022) Authors: Sharma, Hitt; Lalwani, Sanjay; Parekh, Sameer; Pujari, Pramod; Shewale, Sunil; Palkar, Sonali; Hanumante, Neeta; Gokhale, Shilpa; Ks, Jaganathan; Kumar, Rakesh; Sharma, Inderjit; Gairola, Sunil Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗